Zimmer Biomet Holdings (FRA:ZIM) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZIM Zimmer Biomet Holdings Inc FRA:ZIM
80 GF Score
Price €82.28
GF Value €107.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings FFO per Share?

FFO per Share only applies to REITs.

FRA:ZIM
80GF Score
Zimmer Biomet Holdings Inc FRA:ZIM
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zimmer Biomet Holdings (FRA:ZIM) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of €82.28 is trading 23.2% below its estimated GF Value™ of €107.13. GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.

Key valuation signals for FRA:ZIM:

  • FFO per Share:
  • GF Value™: €107.13 vs. price of €82.28 (23.2% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the FRA:ZIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
80GF Score

Get the complete analysis for FRA:ZIM

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€82.28
Price
€107.13
GF Value